Imagin Medical to Report First Fiscal Quarter 2019 Financial Results on February 27, 2019 – Conference Call to Follow
(firmenpresse) -
IMAGIN MEDICAL TO REPORT FIRST FISCAL QUARTER 2019 FINANCIAL RESULTS ON FEBRUARY 27, 2019 - CONFERENCE CALL TO FOLLOW
Vancouver, B.C. and Boston, MA, February 19, 2019 - Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (Imagin or the Company), an emerging leader in the development and commercialization of advanced medical imaging technologies, announced today that its financial results for the first fiscal quarter ended December 31, 2018, will be released after market close on Wednesday, February 27, 2019.
Imagin management will host a conference call at 5:00 p.m. ET to review the financial results and discuss business developments in the period.
Fiscal First Quarter 2019 Results Conference Call Details:
Date:--February 27, 2019
Time:--5:00 p.m. ET
Live Call:-888-428-7458 (Canada and the United States)
862-298-0702 (International)
Replay:--919-882-2331
Replay ID:-43992
The call will also be broadcast live and archived on the Company's website at www.imaginmedical.com under "Events & Presentations."
About Imagin Medical
Imagin Medical is a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive surgeries (MIS). The Company believes its first product, the i/Blue Imaging System, will dramatically improve surgeons ability to visualize cancerous cells by producing higher-quality images more quickly compared with current methods. Based on advanced optics and light sensors, the i/Blue Imaging System employs patented ultrasensitive imaging technology and offers easy-to-use viewing options for more accurate resection. The Companys initial focus is bladder cancer. Learn more at www.imaginmedical.com.
Forward-Looking Statements
Information set forth in the corporate presentation referenced in this press release contains forward-looking statements. These statements reflect managements current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward-looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, many of which are beyond the Companys control. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Specifically, there is no assurance the Companys imaging system will work in the manner expected. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information. The CSE has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.
Contact:
Stephen Kilmer, Investor Relations
Telephone: 647-872-4849
Email: stephen(at)kilmerlucas.com
Jim Hutchens, President & CEO
Telephone: 833-246-2446
Leseranfragen:
" alt="Press Release by Jadar Lithium on Initial Soil Sampling Work done on the Weinebene – Wolfsberg Project Area of AustriaDatum: 19.02.2019 - 14:16 Uhr
Sprache: Deutsch
News-ID 588298
Anzahl Zeichen: 3280
contact information:
Town:
Wien
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 292 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Imagin Medical to Report First Fiscal Quarter 2019 Financial Results on February 27, 2019 – Conference Call to Follow
"
steht unter der journalistisch-redaktionellen Verantwortung von
Imagin Medical (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
